KRAS and neoplasm: Our previous study indicated that colorectal neoplasia developing from UC mucosa (CRNUC) can be divided into two groups: neoplasias with TP53 mutations that develop through the inflammation–dysplasia–carcinoma pathway, and those with KRAS mutations that develop through other pathways [18].